Abbott Laboratories Defibrillator
Abbott Laboratories implanted defibrillators (ICDs and CRT-Ds) manufactured before April 2018 contain authentication bypass vulnerabilities in their wireless RF communication protocol. A nearby attacker can exploit these vulnerabilities to send unauthorized commands to the device, potentially disabling therapy, changing settings, or interfering with the device's function. The vulnerabilities affect Fortify, Fortify Assura, Quadra Assura, Quadra Assura MP, Unify, Unify Assura, Unify Quadra, Promote Quadra, Ellipse, Promote, and Current models. Abbott has released a firmware update that must be applied via the Merlin PCS Programmer at a healthcare facility. Devices manufactured April 25, 2018 or later have the fix preloaded.
- Attacker must be within wireless RF communication range of the implanted device (typically within ~10 meters depending on environment)
- Knowledge of the target device's RF communication protocol
- No valid credentials or authentication required
Patching may require device reboot — plan for process interruption
/api/v1/advisories/5c113d57-b8af-4e07-94a8-4ab339f1019d